Cargando…
Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience
We conducted an observational study to assess the impact of COVID-19 emergency on management and outcomes of patients with Fabry disease referring to our Center in Naples, Italy. No patient of the 129 included reported suspected symptoms; 3 isolated themselves in auto-quarantine for flu-like symptom...
Autores principales: | Riccio, Eleonora, Pieroni, Maurizio, Limoneglli, Giuseppe, Pisani, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386205/ https://www.ncbi.nlm.nih.gov/pubmed/32741663 http://dx.doi.org/10.1016/j.ymgme.2020.07.008 |
Ejemplares similares
-
Medication adherence in Fabry patients treated with migalastat: Real world experience
por: Riccio, Eleonora, et al.
Publicado: (2023) -
Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers
por: Cabona, Corrado, et al.
Publicado: (2020) -
DNA methylation impact on Fabry disease
por: Di Risi, Teodolinda, et al.
Publicado: (2021) -
Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?
por: Pisani, Antonio, et al.
Publicado: (2015) -
Pain in Fabry Disease: Could Spinal Cord Stimulation be a Solution?
por: Buonanno, Pasquale, et al.
Publicado: (2023)